Medicaid Bulletin

Articles published prior to January 2018 are available in the Medicaid Bulletin Archive.

Select date range
Anifrolumab-fnia Injection, for Intravenous Use (Saphnelo™) HCPCS Code J3590: Billing Guidelines
Effective Aug. 18, 2021, the Medicaid and NC Health Choice programs cover anifrolumab-fnia injection
North Carolina Standard & Tailored Plan Tobacco-Free Policy Requirement
Tobacco-related policy requirements go into effect on July 1, 2022.
NC Medicaid EHR Incentive Program Announcements - September, 2021
Two Months Left to Submit Program Year 2021 Attestations; Security Risk Analysis
Interim Process for Submitting Prior Authorization Requests for Beneficiaries Disenrolled to NC Medicaid Direct
Providers are encouraged to confirm which PA types are included in this long-term design.
Clinical Coverage Policy 11A-17 CAR T-Cell Therapy Revision Effective Oct. 1, 2021
Will cover all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines
SPECIAL BULLETIN COVID-19 #178: Temporary Provisions for COVID Surge: Post-Acute PA Exceptions and Hospital at Home Program
Temporary Suspension of Prior Authorization for Post-Acute Placements and Temporary Availability of the Hospital at Home Program
SPECIAL BULLETIN COVID-19 #177: Casirivimab and Imdevimab Approved for Emergency Use
Casirivimab and Imdevimab have been given emergency use authorization for treatment of mild to moderate COVID-19 in some patients.
Single State Audit SFY2021
OSA has begun the Single Audit for state fiscal year 2021
Medicaid Claims Documentation: 2020 Single State Audit
Tips for providers to reduce the likelihood of future documentation errors
Influenza Vaccine and Reimbursement Guidelines for 2021-2022 for NC Medicaid and NC Health Choice
Billing codes for Medicaid beneficiaries